about
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deploymentA long neglected world malaria map: Plasmodium vivax endemicity in 2010Artemisinin combination therapy for vivax malariaLung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation"Asymptomatic" Malaria: A Chronic and Debilitating Infection That Should Be TreatedA systematic review of sub-microscopic Plasmodium vivax infectionReview of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportMaking the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugsPrimaquine radical cure of Plasmodium vivax: a critical review of the literatureComa associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, IndonesiaA triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor (DSM421) with improved drug-like properties for treatment and prevention of malariaIdarubicin cardiotoxicity in acute myeloid leukaemiaSafety profile of L-arginine infusion in moderately severe falciparum malariaAn analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testingPlasmodium malariae and P. ovale genomes provide insights into malaria parasite evolutionNonlinear mixed-effects modelling of in vitro drug susceptibility and molecular correlates of multidrug resistant Plasmodium falciparumA randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokineticsMajor burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance studyCharacterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingGenetic diversity and population structure of Plasmodium vivax in Central ChinaMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy numberVivax malaria: neglected and not benignA novel multiple-stage antimalarial agent that inhibits protein synthesisDrug resistant falciparum malaria: clinical consequences and strategies for prevention.Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencingAnalysis of ex vivo drug response data of Plasmodium clinical isolates: the pros and cons of different computer programs and online platforms.The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trialsThe challenges of introducing routine G6PD testing into radical cure: a workshop report.Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.Severe congenital malaria acquired in utero.Diagnosis and treatment of Plasmodium vivax malaria.Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia.Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.Improving case definitions for severe malaria.Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria.Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
P50
Q21090072-49D63E8D-6258-4081-A3AF-7520FBA43BDCQ21144495-5FDFD214-7341-4393-9998-7021873E37A1Q24622539-3BB97ECF-601E-4B29-8485-856B2B29EE1CQ24653650-075469AF-B6A4-4CFF-A008-FE200B7A0FDFQ26771205-D98EC204-A7F7-41F9-94E7-2AC32FE624A7Q26782683-C73407EB-127C-418C-8E28-2ECA571DBC89Q27024922-214C37AC-776A-4516-8D96-6C8473854121Q27025529-8CE3799C-7702-4272-94AC-B835AE56DCE5Q27027939-D3E2647C-4A85-4B9B-A79B-1707CA11EF19Q27306352-F7F2EDB7-1103-42B7-92E8-109B7ADA00A4Q27728080-5FD4DDDE-66A7-4FF0-BC40-BEDC4F80C1A9Q28327565-591790F0-DA9E-412F-BBB7-5F12844339A4Q28472935-D7A159FA-365C-48D1-8464-748515A59895Q28482113-376C1AF9-B2BC-41DE-BDB1-B72E0D9ADEE2Q28529647-D7AD826D-1ABD-4AD4-BF41-491BB1D8A39FQ28534820-328E50C7-D08A-455B-9DF4-C509F2F39F45Q28534942-482855D9-2F46-4E18-96F4-B31D52610BDAQ28537653-06D3A588-8C3A-4EE6-9D9F-A8E0CC1D5E15Q28554466-833F3F8E-FABD-40CB-A415-EF460605A80AQ28655779-2AC32453-F3B3-4CED-A7F8-A15215C7B399Q29615128-2632D3C2-D41C-47E9-8C5B-67D3645B403EQ29619167-66244C0B-A563-47B1-9EC5-F160011E57FEQ30044020-2EDC3352-FC8F-4E5A-9B97-2BC133F8C002Q30329339-9305DA47-E15F-45B6-917B-8C0925370E50Q30459215-FA7035B4-4411-4185-982E-0D1DE4CE7EAEQ30489045-B40244B1-6BE7-4232-82C6-403B03FFF987Q30491343-C335E1B0-EA36-4F9E-9FCE-D603EBF37ECFQ30666192-7B5F6DD2-7618-4B56-9219-BCEDABED6D2CQ30867699-97717D4C-E2A4-4570-B6BB-CE23C8843342Q30980068-70C3410F-04C6-4A3A-A992-FAAB528F4610Q31107865-7B197ECA-ABEE-4386-A2F9-0E50A5E9DA43Q31153944-B8788BC2-3A1E-4FB9-A63C-A24C8305115AQ33226507-DC97C120-1FF8-47ED-BDCC-C75A6DAECF9EQ33259717-421F43D3-0340-499C-9D59-181E765B3D3EQ33276757-0C9CE6B5-F31C-434B-B024-7CFE45A4ECACQ33279066-16939851-51ED-4C1C-91F2-897EBA7B65E2Q33294900-EC96817B-17D9-4690-92D0-3E7BDC585BE9Q33298467-B8FC50CF-8B50-4F16-9F0E-FD9CD2E10182Q33303521-5664A044-EA98-421F-AA56-AE3438222A0AQ33304430-F7685207-6641-4D62-BD17-BC2CFC519CD8
P50
description
professor of tropical medicine and physician
@en
wetenschapper
@nl
name
Richard Price
@af
Richard Price
@an
Richard Price
@ast
Richard Price
@bar
Richard Price
@br
Richard Price
@ca
Richard Price
@co
Richard Price
@cs
Richard Price
@cy
Richard Price
@da
type
label
Richard Price
@af
Richard Price
@an
Richard Price
@ast
Richard Price
@bar
Richard Price
@br
Richard Price
@ca
Richard Price
@co
Richard Price
@cs
Richard Price
@cy
Richard Price
@da
altLabel
Ric Price
@af
Ric Price
@an
Ric Price
@ast
Ric Price
@bar
Ric Price
@br
Ric Price
@ca
Ric Price
@co
Ric Price
@cs
Ric Price
@cy
Ric Price
@da
prefLabel
Richard Price
@af
Richard Price
@an
Richard Price
@ast
Richard Price
@bar
Richard Price
@br
Richard Price
@ca
Richard Price
@co
Richard Price
@cs
Richard Price
@cy
Richard Price
@da
P108
P1153
P214
P244
P1153
55544802200
57019514500
7403298476
P1960
1MeVSH0AAAAJ
P2002
ricprice99
P2038
P21
P214
P244
no2013074810
P31
P496
0000-0003-2000-2874
P734
P735
P7859
lccn-no2013074810